Senostatics

4 papers1 finding

Outcomes

1

Senescence-associated secretory phenotype (SASP)

downin humans1

1 study

Senostatics inhibit senescence-associated secretory phenotype (SASP) in humans.
“senostatics suppress the SASP, improving the tumor microenvironment and enhancing traditional therapies.”
Reviewin cervical cancer
Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential
International immunopharmacology17 Jun 2026

More on Senescence-associated secretory phenotype (SASP)

Latest

2 in 12 months

Advances in Gerontology29 Jun

The effect of geroprotectors on life expectancy: Mechanisms of action and clinical potential

ReviewInterventions

International Immunopharmacology18 Jun

Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential

ReviewCervical cancer

Biochemical Pharmacology26 Sep

Pursuing healthy aging and longevity through natural product and stem cell-driven rejuvenation

ReviewInterventions

Biomedicine & Pharmacotherapy27 Sep

Targeted delivery strategy: A beneficial partner for emerging senotherapy

ReviewInterventions